Obesity And Health

Next-gen pipeline spans higher-dose, combination and oral therapies; company says it can meet India's demand for GLP-1 medicines as the market expands

Updated On: 01 Oct 2026 | 1:34 AM IST

The company is racing ​to reassure markets that ​it can navigate patent expirations for semaglutide - the active ingredient in its anti-obesity ​drugs Ozempic and Wegovy franchises, in the early 2030s

Updated On: 21 Sep 2026 | 3:30 PM IST

In a 16-page letter dated April 10 and sent to the Drugs Controller General of India, Lilly said it had halted the campaign 'out of an abundance of regulatory caution' following a March advisory

Updated On: 12 May 2026 | 8:20 AM IST

Regulators have been asked to track adverse events as India tightens oversight on popular obesity drugs amid rising demand and concerns over misuse and misleading promotions

Updated On: 04 Apr 2026 | 11:18 AM IST

A large real-world study finds patients stopping semaglutide or tirzepatide may not regain as much weight as expected, aided by treatment switches, restarts, and lifestyle support

Updated On: 18 Mar 2026 | 1:48 PM IST

Drug regulator warns pharma companies that obesity awareness drives linked to GLP-1 drugs could amount to misleading promotion of prescription medicines

Updated On: 11 Mar 2026 | 11:52 PM IST

With obesity rising across age groups, World Obesity Day 2026 calls for global action, better policies and a shift away from stigma to protect long-term health

Updated On: 04 Mar 2026 | 12:51 PM IST

World Obesity Day: Is weight loss after 60 always healthy? Doctors explain who benefits, when it can backfire, and why strength, mobility and nutrition may matter more than the scale

Updated On: 04 Mar 2026 | 12:28 PM IST

As muscle mass declines and abdominal fat rises with age, BMI can be misleading. A new study finds waist-to-height ratio better reflects real obesity risk in older adults

Updated On: 08 Jan 2026 | 11:35 AM IST

India still has a critical advantage: ultra-processed foods account for a very small share of current diets

Updated On: 02 Jan 2026 | 9:22 AM IST

Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry, according to Sun Pharma Managing Director Kirti Ganorkar. Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes, high blood sugar, and obesity by regulating insulin production. India, known for its generic drug industry, is rapidly transforming into a major hub for the global weight management industry, amid rapid increase in obesity-led disease burden. "Improving access to GLP-1 treatments in the coming years will be a key driver for the Indian pharmaceutical industry, helping address the growing burden of lifestyle diseases such as obesity and diabetes," Ganorkar told PTI. Combined with AI-enabled digital tools for early disease detection and monitoring, and personalised medicine choices, the industry will continue to drive innovation that supports accessibility, affordability, and ..

Updated On: 28 Dec 2025 | 10:28 PM IST

Why does belly fat creep up after 30 even if nothing has changed? A California-based gastroenterologist trained at AIIMS explains the science behind it and what can help reverse it

Updated On: 23 Dec 2025 | 12:08 PM IST

From fibremaxxing and longevity clinics to GLP-1 drugs, AI hospitals and workplace mental health, 2025 reshaped how India talks about prevention, ageing and wellbeing

Updated On: 23 Dec 2025 | 10:47 AM IST

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural support rather than relying on medication alone

Updated On: 02 Dec 2025 | 3:20 PM IST

A new clinical trial shows that kalonji, long used in Indian kitchens, may help lower cholesterol and slow fat formation, offering a natural metabolic boost alongside regular diet and lifestyle habits

Updated On: 25 Nov 2025 | 11:19 AM IST

Researchers warn that the findings reflect a growing global health crisis, as outdated BMI standards fail to capture hidden fat-linked risks contributing to chronic disease.

Updated On: 16 Oct 2025 | 3:54 PM IST

Children with "unhealthy obesity" were three times more likely born from high-risk pregnancies, linking early-life factors to later metabolic health risks

Updated On: 29 Sep 2025 | 7:07 AM IST

Ultra-processed foods, aggressive marketing and weak regulations are driving obesity among children. Unicef urges governments to act now to protect children's health and future potential

Updated On: 11 Sep 2025 | 12:59 PM IST

A global study reveals that millions go undiagnosed with diabetes. Researchers call for better education, early screening, and affordable treatment access

Updated On: 10 Sep 2025 | 12:34 PM IST

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness

Updated On: 14 Jul 2025 | 11:41 PM IST